RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 61 filers reported holding RECRO PHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $17,000 | -10.5% | 10,400 | -56.6% | 0.00% | 0.0% |
| Q2 2022 | $19,000 | -60.4% | 23,963 | -10.9% | 0.00% | -50.0% |
| Q1 2022 | $48,000 | -9.4% | 26,884 | -13.5% | 0.00% | 0.0% |
| Q4 2021 | $53,000 | -1.9% | 31,067 | +19.1% | 0.00% | -33.3% |
| Q3 2021 | $54,000 | -14.3% | 26,081 | -4.7% | 0.00% | -25.0% |
| Q2 2021 | $63,000 | -47.9% | 27,381 | -36.9% | 0.00% | -33.3% |
| Q1 2021 | $121,000 | +13.1% | 43,422 | +15.7% | 0.01% | +20.0% |
| Q4 2020 | $107,000 | +8.1% | 37,516 | -20.6% | 0.01% | 0.0% |
| Q3 2020 | $99,000 | – | 47,263 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 850,129 | $2,423,000 | 0.65% |
| Newtyn Management, LLC | 700,000 | $1,995,000 | 0.46% |
| Portolan Capital Management | 1,293,376 | $3,686,000 | 0.34% |
| Rubric Capital Management LP | 1,076,587 | $3,068,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 99,046 | $282,000 | 0.04% |
| Alyeska Investment Group, L.P. | 736,821 | $2,100,000 | 0.03% |
| STEPHENS INC /AR/ | 510,569 | $1,455,000 | 0.03% |
| Clear Harbor Asset Management, LLC | 46,682 | $133,000 | 0.02% |
| WYNNEFIELD CAPITAL INC | 13,000 | $37,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 451,301 | $1,286,000 | 0.01% |